Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Konkret geht es um den Diabetes-Patienten mit kardiovaskulären Erkrankungen oder Risiken, die Herzinsuffizienz sowie die kardiovaskuläre Primär- und Sekundärprävention. Sind Sie hier schon auf dem neuesten Stand? Unsere Experten beleuchten, wo und warum das bisherige Procedere geändert werden soll und was in der Praxis sinnvoll ist. Holen Sie sich Ihr Update und 2 CME-Punkte beim MMW-Webinar am 24. April von 17.30 bis 19 Uhr. 
Erweiterte Suche
Anmelden
nach oben
AIDS and Behavior
Erschienen in: AIDS and Behavior 1/2018

15.05.2018 | Original Paper

Syringe Sharing in Drug Injecting Dyads: A Cross-Classified Multilevel Analysis of Social Networks

Erschienen in: AIDS and Behavior | Sonderheft 1/2018

Einloggen, um Zugang zu erhalten

Abstract

We examined the association of dyadic-level factors with syringe sharing among people who inject drugs (PWID) in Kerman, Iran. In a cross-sectional study, we collected data on 329 drug-injecting dyads by individual face-to-face interviews. An injecting dyad was defined as 2 PWID who knew each other and injected drugs together during the last 6 months. If they reported at least 1 occasion of syringe sharing, the dyad was considered high-risk. Dyadic-level factors associated with syringe sharing were assessed using cross-classified multilevel logistic regression. The rate of syringe sharing was significantly higher for dyads who were more intimate (adjusted odds ratio [AOR] 4.5, CI 95%, 2.3–8.6), who had instrumental support (AOR 2.1, 95% CI 1.1–4.5), and who pooled money for drugs (AOR 4.1, 95% CI 2.0–8.3). The rate was lower in same-sex dyads (AOR 0.4, 95% CI 0.2–0.9) and in dyads who shared health information (AOR 0.5, 95% CI 0.2–0.9). Findings highlight close-peer influences on syringe-sharing behavior.
Literatur
1.
Nikfarjam A, Shokoohi M, Shahesmaeili A, Haghdoost AA, Baneshi MR, Haji-Maghsoudi S, et al. National population size estimation of illicit drug users through the network scale-up method in 2013 in Iran. Int J Drug Policy. 2016;31:147–52.CrossRefPubMed
2.
Amiri FB, Mostafavi E, Mirzazadeh A. HIV, HBV and HCV coinfection prevalence in Iran—a systematic review and meta-analysis. PLoS ONE. 2016;11(3):e0151946.CrossRef
3.
Mumtaz GR, Weiss HA, Thomas SL, Riome S, Setayesh H, Riedner G, et al. HIV among people who inject drugs in the Middle East and North Africa: systematic review and data synthesis. PLoS Med. 2014;11(6):e1001663.CrossRefPubMedPubMedCentral
4.
Khajehkazemi R, Osooli M, Sajadi L, Karamouzian M, Sedaghat A, Fahimfar N, et al. HIV prevalence and risk behaviours among people who inject drugs in Iran: the 2010 National Surveillance Survey. Sex Transm Infect. 2013;89(Suppl 3):29–32.CrossRef
5.
Pasa MK, Alom KR, Bashri Z, Vermund SH. Sharing of needles and syringes among men who inject drugs: HIV risk in Northwest Bangladesh. PLoS ONE. 2016;11(2):e0148276.CrossRefPubMedPubMedCentral
6.
Otiashvili D, Latypov A, Kirtadze I, Ibragimov U, Zule W. Drug preparation, injection, and sharing practices in Tajikistan: a qualitative study in Kulob and Khorog. Subst Abuse Treat Prev Policy. 2016;11(1):21.CrossRefPubMedPubMedCentral
7.
Beletsky L, Heller D, Jenness SM, Neaigus A, Gelpi-Acosta C, Hagan H. Syringe access, syringe sharing, and police encounters among people who inject drugs in New York City: a community-level perspective. Int J Drug Policy. 2014;25(1):105–11.CrossRefPubMed
8.
Rhodes T, Mikhailova L, Sarang A, Lowndes CM, Rylkov A, Khutorskoy M, et al. Situational factors influencing drug injecting, risk reduction and syringe exchange in Togliatti City, Russian Federation: a qualitative study of micro risk environment. Soc Sci Med. 2003;57(1):39–54.CrossRefPubMed
9.
Ahmed T, Long TN, Huong PT, Stewart DE. Drug injecting and HIV risk among injecting drug users in Hai Phong, Vietnam: a qualitative analysis. BMC Public Health. 2015;15(1):32.CrossRefPubMedPubMedCentral
10.
Thanh DC, Moland KM, Fylkesnes K. The context of HIV risk behaviours among HIV-positive injection drug users in Viet Nam: moving toward effective harm reduction. BMC Public Health. 2009;9(1):98.CrossRefPubMedPubMedCentral
11.
Himmich H, Madani N. The state of harm reduction in the Middle East and North Africa: a focus on Iran and Morocco. Int J Drug Policy. 2016;31:184–9.CrossRefPubMed
12.
Alam Mehrjerdi Z, Noori R, Dolan K. Opioid use, treatment and harm reduction services: the first report from the Persian Gulf region. J Subst Use. 2015;1–7.
13.
Khajehkazemi R, Osooli M, Sajadi L, Karamouzian M, Sedaghat A, Fahimfar N, et al. HIV prevalence and risk behaviours among people who inject drugs in Iran: the 2010 National Surveillance Survey. Sex Transm Infect. 2013;1–4.
14.
Kazerooni A, Joolaei H, Parsa N. Knowledge and attitude of male intravenous drug users on HIV/AIDS associated high risk behaviors in Shiraz Pir-Banon jail, Fars Province, Southern Iran. Iranian Red Crescent Med J. 2010;12(3):334–6.
15.
Rezaie F, Farhadi MH, Farhoudian A, Najafi M, Bazrafshan A, Higgs P, et al. Access to needle and syringe programs and the relationship to equipment sharing among people who inject drugs in Kermanshah, Iran. J Subst Use. 2016;1–6.
16.
Nazari SSH, Noroozi M, Soori H, Noroozi A, Mehrabi Y, Hajebi A, et al. The effect of on-site and outreach-based needle and syringe programs in people who inject drugs in Kermanshah, Iran. Int J Drug Policy. 2016;27:127–31.CrossRefPubMed
17.
Amin-Esmaeili M, Rahimi-Movaghar A, Gholamrezaei M, Razaghi EM. Profile of people who inject drugs in Tehran, Iran. Acta Medica Iranica. 2017;54(12):793–805.
18.
Habibi M, Farmanfarmaee S, Darharaj M, Khoshnood K, Matacotta JJ, O’Bryan J. Predictors of HIV risk behavior in iranian women who inject drugs. J Drug Issues. 2017;0022042617693383.
19.
Noori R, Narenjiha H, Aghabakhshi H, Habibi G, Khoshkrood Mansoori B. Methadone maintenance therapy outcomes in Iran. Subst Use Misuse. 2012;47(7):767–73.CrossRefPubMed
20.
Galea S, Riddle M, Kaplan GA. Causal thinking and complex system approaches in epidemiology. Int J Epidemiol. 2010;39(1):97–106.CrossRefPubMed
21.
Luke DA, Harris JK. Network analysis in public health: history, methods, and applications. Annu Rev Public Health. 2007;28:69–93.CrossRefPubMed
22.
Sherman SG, Latkin CA, Gielen AC. Social factors related to syringe sharing among injecting partners: a focus on gender. Subst Use Misuse. 2001;36(14):2113–36.CrossRefPubMed
23.
Friedman SR, Curtis R, Neaigus A, Jose B, Des Jarlais DC. Social networks, drug injectors lives, and HIV/AIDS. Springer Science & Business Media; 2006.
24.
Morris MD, Bates A, Andrew E, Hahn J, Page K, Maher L. More than just someone to inject drugs with: injecting within primary injection partnerships. Drug Alcohol Depend. 2015;156:275–81.CrossRefPubMedPubMedCentral
25.
Gyarmathy VA, Li N, Tobin KE, Hoffman IF, Sokolov N, Levchenko J, et al. Injecting equipment sharing in Russian drug injecting dyads. AIDS Behav. 2010;14(1):141–51.CrossRefPubMed
26.
O’Malley AJ. The analysis of social network data: an exciting frontier for statisticians. Stat Med. 2013;32(4):539–55.CrossRefPubMed
27.
McMahon JM, Pouget ER, Tortu S. A guide for multilevel modeling of dyadic data with binary outcomes using SAS PROC NLMIXED. Comput Stat Data Anal. 2006;50(12):3663–80.CrossRefPubMedPubMedCentral
28.
Leckie G. Module 12: cross-classified multilevel models. LEMMA online course: University of Bristol, Centre for Multilevel Modelling; 2013.
29.
Fielding A, Goldstein H. Cross-classified and multiple membership structures in multilevel models: an introduction and review; 2006.
30.
31.
Shokoohi M, Baneshi MR, Ali-akbar H. Size estimation of groups at high risk of HIV/AIDS using network scale up in Kerman, Iran. Int J Prev Med. 2012;3(7):471–6.PubMedPubMedCentral
32.
Friedman SR, Curtis R, Neaigus A, Jose B, Des Jarlais DC. Syringe sharing and the social characteristics of drug-injecting dyads. Social Networks, Drug Injectors’ Lives, and HIV/AIDS; 2002. p. 143–56.
33.
Khajehkazemi R, Haghdoost A, Navadeh S, Setayesh H, Sajadi L, Osooli M, et al. Risk and vulnerability of key populations to HIV infection in Iran; knowledge, attitude and practises of female sex workers, prison inmates and people who inject drugs. Sexual Health. 2014;11(6):568–74.CrossRefPubMed
34.
Rahnama R, Mohraz M, Mirzazadeh A, Rutherford G, McFarland W, Akbari G, et al. Access to harm reduction programs among persons who inject drugs: findings from a respondent-driven sampling survey in Tehran, Iran. Int J Drug Policy. 2014;25(4):717–23.CrossRefPubMedPubMedCentral
35.
Jahanbakhsh F, Mostafavi E, Haghdoost A. The potential for HIV self-testing in Iran. Int J Prev Med. 2016;6(114).
36.
Shahesmaeili A, Haghdoost AA, Soori H. Network location and risk of human immunodeficiency virus transmission among injecting drug users: results of multiple membership multilevel modeling of social networks. Addiction Health. 2015;7(1–2):1–13.PubMedPubMedCentral
37.
De P, Cox J, Boivin J-F, Platt RW, Jolly AM. The importance of social networks in their association to drug equipment sharing among injection drug users: a review. Addiction. 2007;102(11):1730–9.CrossRefPubMed
38.
Loxley W, Ovenden C. Friends and lovers: needle sharing in young people in Western Australia. AIDS Care. 1995;7(3):337–52.CrossRefPubMed
39.
Latkin CA, Sherman S, Knowlton A. HIV prevention among drug users: outcome of a network-oriented peer outreach intervention. Health Psychol. 2003;22(4):332.CrossRefPubMed
40.
Cepeda JA, Odinokova VA, Heimer R, Grau LE, Lyubimova A, Safiullina L, et al. Drug network characteristics and HIV risk among injection drug users in Russia: the roles of trust, size, and stability. AIDS Behav. 2011;15(5):1003–10.CrossRefPubMedPubMedCentral
41.
Shaw SY, Shah L, Jolly AM, Wylie JL. Determinants of injection drug user (IDU) syringe sharing: the relationship between availability of syringes and risk network member characteristics in Winnipeg, Canada. Addiction. 2007;102(10):1626–35.CrossRefPubMed
42.
Koester S, Glanz J, Barón A. Drug sharing among heroin networks: implications for HIV and hepatitis B and C prevention. AIDS Behav. 2005;9(1):27–39.CrossRefPubMed
43.
Grund JP, Kaplan CD, Adriaans NF, Blanken P. Drug sharing and HIV transmission risks: the practice of frontloading in the Dutch injecting drug user population. J Psychoact Drugs 1991;23(1):1–10
44.
El-Bassel N, Shaw SA, Dasgupta A, Strathdee SA. People who inject drugs in intimate relationships: it takes two to combat HIV. Curr HIV/AIDS Rep. 2014;11(1):45–51.CrossRefPubMedPubMedCentral
45.
Grund J-PC, Friedman SR, Stern LS, Jose B, Neaigus A, Curtis R, et al. Syringe-mediated drug sharing among injecting drug users: patterns, social context and implications for transmission of blood-borne pathogens. Soc Sci Med. 1996;42(5):691–703.
46.
Booth RE, Lehman WE, Latkin CA, Dvoryak S, Brewster JT, Royer MS, et al. Individual and network interventions with injection drug users in 5 Ukraine cities. Am J Public Health. 2011;101(2):336–43.CrossRefPubMedPubMedCentral
47.
Smyrnov P, Williams LD, Korobchuk A, Sazonova Y, Nikolopoulos GK, Skaathun B, et al. Risk network approaches to locating undiagnosed HIV cases in Odessa, Ukraine. J Int AIDS Soc. 2018;21(1):e25040.CrossRefPubMedCentral
48.
Nikolopoulos GK, Pavlitina E, Muth SQ, Schneider J, Psichogiou M, Williams LD, et al. A network intervention that locates and intervenes with recently HIV-infected persons: the Transmission Reduction Intervention Project (TRIP). Sci Rep. 2016;6:38100.CrossRefPubMedPubMedCentral
49.
Latkin CA, Smith MK, Ha TV, Mo TT, Zelaya C, Sripaipan T, et al. Roles and functions of social networks among men who use drugs in ART initiation in Vietnam. AIDS Behav. 2016;20(11):2782–9.CrossRefPubMedPubMedCentral
50.
Marshall Z, Dechman M, Minichiello A, Alcock L, Harris G. Peering into the literature: a systematic review of the roles of people who inject drugs in harm reduction initiatives. Drug Alcohol Depend. 2015;151:1–14.CrossRefPubMed
51.
Smyrnov P, Williams LD, Korobchuk A, Sazonova Y, Nikolopoulos GK, Skaathun B, et al. Risk network approaches to locating undiagnosed HIV cases in Odessa, Ukraine. J Int AIDS Soc. 2018;21(1).
52.
Hosseini Hooshyar S, Ranjbar E, Sharifi H, Shafiei M, Tayeri K, Haghdoost A, et al. Evaluating the HIV continuum of care and treatment in a low prevalence city in Iran: Kerman HIV-Friendly City initiative. East Afr J Appl Health Monit Eval. 2018(2).
53.
Medley A, Kennedy C, O’Reilly K, Sweat M. Effectiveness of peer education interventions for HIV prevention in developing countries: a systematic review and meta-analysis. AIDS Educ Prev. 2009;21(3):181–206.CrossRefPubMedPubMedCentral
54.
Simoni JM, Nelson KM, Franks JC, Yard SS, Lehavot K. Are peer interventions for HIV efficacious? A systematic review. AIDS Behav. 2011;15(8):1589–95.CrossRefPubMedPubMedCentral
55.
Valente TW, Gallaher P, Mouttapa M. Using social networks to understand and prevent substance use: a transdisciplinary perspective. Subst Use Misuse. 2004;39(10–12):1685–712.CrossRefPubMed
Metadaten
Titel
Syringe Sharing in Drug Injecting Dyads: A Cross-Classified Multilevel Analysis of Social Networks
Publikationsdatum
15.05.2018
Erschienen in
AIDS and Behavior / Ausgabe Sonderheft 1/2018
Print ISSN: 1090-7165
Elektronische ISSN: 1573-3254
DOI
https://doi.org/10.1007/s10461-018-2144-z

Weitere Artikel der Sonderheft 1/2018

AIDS and Behavior 1/2018 Zur Ausgabe

Original Paper

Mother-to-Child Transmission of HIV and HIV-Free Survival in Swaziland: A Community-Based Household Survey

Original Paper

Characterization of HIV Recent Infection Among High-Risk Men at Public STI Clinics in Mumbai

Original Paper

Risk Behaviors and Perceptions Among Self-identified Men Who Have Sex with Men (MSM), Bisexuals, Transvestites, and Transgender Women in Western Guatemala

OriginalPaper

Home-Based Care and Perceived Quality of Life Among People Living with HIV in Ho Chi Minh City, Viet Nam

Original Paper

Emergency Contraceptive Pills (ECP) Knowledge, Attitudes, and Practices Among Women Working in the Entertainment Industry and Men in the Trucking Industry, Bhutan

Original Paper

An Empiric Risk Score to Guide PrEP Targeting Among MSM in Coastal Kenya

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

19.04.2024 | Vorhofflimmern | Nachrichten

Parodontalbehandlung verbessert Prognose bei Katheterablation

19.04.2024 | EAU 2024 | Kongressbericht | Nachrichten

Prostatakarzinom: EU initiiert neues Screeningkonzept

19.04.2024 | EAU 2024 | Kongressbericht | Nachrichten

Blasenkarzinom – Biomarker statt Zytologie?

18.04.2024 | Arterielle Hypertonie | Nachrichten

Antihypertensiva schützen auch alte Menschen noch vor Demenz
weitere anzeigen

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen
Bildnachweise